The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence (Q36249221)

13 August 2017

1 reference

title

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence (English)

1 reference

13 August 2017

1 reference

Jian Gu

1

1 reference

13 August 2017

H Barton Grossman

series ordinal

2

1 reference

13 August 2017

Colin P Dinney

series ordinal

3

1 reference

13 August 2017

Xifeng Wu

series ordinal

4

1 reference

13 August 2017

language of work or name

1 reference

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

6

1 reference

13 August 2017

575-584

1 reference

13 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Analysis of the performance of pathologists in the grading of bladder tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

21 January 2018

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

What we could do now: molecular pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Molecular pathways in bladder cancer: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Molecular markers in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Markers for recurrence of superficial bladder cancer: what is valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Can biological markers predict recurrence and progression of superficial bladder cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Molecular prognostication in bladder cancer--a current perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Microarray and histopathological analysis of tumours: the future and the past?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Clinical proteomics--insights into pathologies and benefits for patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Barrett's esophagus: disregulation of cell cycling and intercellular adhesion in the metaplasia-dysplasia-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Immunotherapy for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

BCG immunotherapy of bladder cancer: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Cytokine function: a study in biologic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

An investigation of polymorphism in the interleukin-10 gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Single-nucleotide polymorphism g.1548G > A (E469K) in human ICAM-1 gene affects mRNA splicing pattern and TPA-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.6.575

21 January 2018

Identifiers

DOI

10.2217/14622416.6.6.575

1 reference

13 August 2017

1 reference